IOL Chemicals And Pharmaceuticals shareholding pattern

IOLCP

70.51

2.77 (-3.78%)
Last updated on 2 Feb, 2026 | 12:20 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

IOL Chemicals And Pharmaceuticals Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

52.62%

Mutual Fund

0.02%

Insurance

0%

Foreign Institutional Investors

2.08%

Domestic Institutional Investors

0%

Retail

45.28%

Others

0%

Total Promoters
MAR '25
52.62%
JUN '25
52.62%
SEP '25
52.62%
DEC '25
52.62%

Summary

For Year 2025-26, IOL Chemicals And Pharmaceuticals reports the following shareholding: Total Promoters at 52.62%, Mutual Fund at 0.02%, Insurance at 0%, Foreign Institutional Investors at 2.08%, Domestic Institutional Investors at 0%, and Retail at 45.28%. This breakdown provides a quick snapshot of ownership distribution for IOL Chemicals And Pharmaceuticals in 2025-26.

IOL Chemicals And Pharmaceuticals FAQs

As of 02-2026, the promoter shareholding in IOL Chemicals And Pharmaceuticals stands at 52.62% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of IOL Chemicals And Pharmaceuticals is 2.08% and 0% respectively.

The retail shareholding of the IOL Chemicals And Pharmaceuticals is 45.28%.

Changes in shareholding patterns of IOL Chemicals And Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of IOL Chemicals And Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.